OncLive® Expands its Roster of Strategic Alliance Partners With Sylvester Comprehensive Cancer Center

OncLive®â€¯ has added the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine to its Strategic Alliance Partnership program, the company announced today.  Under the new partnership, OncLive’s editorial and marketing teams will share news about research and other breakthroughs in cancer care coming from the Sylvester Comprehensive Cancer Center.

Researchers at Sylvester recently developed a new technique for growing ovarian cancer cells that mimic the cells in the original tumor in long-term cultures, enabling physicians to more precisely target therapies for patients. Neurosurgeons at the center are also among the first in Miami-Dade and Broward Counties to use the NICO BrainPath system to remove tumors, especially deeply embedded ones, using incisions as small as a dime.

The Sylvester Comprehensive Cancer Center is one of only four cancer centers recognized by the state of Florida as a Cancer Center of Excellence.

“This combination of statewide recognition for excellence and the use of innovative technologies for patient care keeps the Sylvester Comprehensive Cancer Center at the forefront of cancer care and research,” said Mike Hennessy Jr., president of Intellisphere Oncology and Healthcare Specialty Group, part of the Plainsboro, N.J.-based Michael J. Hennessy Associates, Inc. (MJH) family of businesses. “We’re certain the center will continue to provide exciting news, and we’re excited to share that news with our customers.”

The center was the recent recipient of $3.6 million from the Pap Corps, a 21,000 all-volunteer fundraising organization dedicated to supporting cancer research. The donation is earmarked to help the Sylvester Comprehensive Cancer Center become a National Cancer Institute-designated cancer center.

“Our research, our educational efforts and our dedication to patients are helping transform cancer care in South Florida and beyond,” said Director Stephen D. Nimer, M.D. “Our partnership with OncLive will help us share the news about the potentially life-saving advances at the center.”

The Sylvester Comprehensive Cancer Center joins more than 50 other leading cancer centers, nursing schools and physician groups around the country in partnering with OncLive.

“The Strategic Alliance Partnership program serves everyone committed to fighting cancer. When we work together and share our knowledge broadly, we are better armed to improve our efforts to overcome this devastating disease,” Hennessy added. 

About OncLive

OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News and Contemporary Oncology. OncLive offers oncology professionals resources and information they need to provide the best care for their patients. Intellisphere, LLC, a leading provider of healthcare publishing, research and education, is part of the Michael J. Hennessy Associates, Inc. (MJH) family of businesses, based in Plainsboro, NJ. MJH also includes the acclaimed CURE Media Group, which combines science and humanity to make cancer understandable. Its flagship product is CURE®â€¯magazine, the largest consumer publication in the U.S. focused entirely on cancer, reaching cancer patients, cancer centers and advocacy groups. To learn more, please visit www.OncLive.com. 

About Sylvester Comprehensive Cancer Center 

Sylvester Comprehensive Cancer Center, part of UHealth — University of Miami Health System and the University of Miami Miller School of Medicine, is among the nation’s leading cancer centers and South Florida's only Cancer Center of Excellence. With the combined strength of more than 115 cancer researchers and 130 cancer physician specialists, Sylvester is focused on providing the next generation of cancer care, delivering precision cancer medicine in the form of targeted therapies, focused immunotherapies, oncolytic tumor viruses, and stem cell transplantation and patient-specific support services to each patient. Our comprehensive diagnostics coupled with teams of scientific and clinical experts who specialize in one or two specific types of cancer, enable us to better understand each patient’s individual cancer and develop treatments that target the cells and the genes that drive the cancer's growth and survival. At Sylvester, patients have access to more treatment options and more cancer-focused clinical trials than most hospitals in the southeastern United States. To better serve current and future patients, Sylvester has a network of conveniently located outpatient treatment facilities in Miami, Kendall, Hollywood, Plantation, Deerfield Beach and Coral Springs, with plans to open in Coral Gables in 2016. For more information, please visit www.sylvester.org.